DXJ:NYE-WisdomTree Japan Hedged Equity Fund (USD)

ETF | Japan Stock |

Last Closing

USD 106.25

Change

+0.25 (+0.24)%

Market Cap

N/A

Volume

0.41M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Japan Stock

Symbol Name Price(Change) Market Cap
FLJP Franklin FTSE Japan ETF

+0.01 (+0.03%)

USD 2.18B
DBJP Xtrackers MSCI Japan Hedged Eq..

+0.09 (+0.13%)

USD 0.44B
FLJH Franklin FTSE Japan Hedged ETF

-0.05 (-0.16%)

USD 0.08B
DFJ WisdomTree Japan SmallCap Divi..

+0.27 (+0.33%)

N/A
EWJ iShares MSCI Japan ETF

+0.10 (+0.14%)

N/A
GSJY Goldman Sachs ActiveBeta® Jap..

-0.01 (-0.03%)

N/A
HEWJ iShares Currency Hedged MSCI J..

+0.01 (+0.02%)

N/A
JPXN iShares JPX-Nikkei 400 ETF

+0.16 (+0.21%)

N/A
SCJ iShares MSCI Japan Small-Cap E..

+0.05 (+0.06%)

N/A

ETFs Containing DXJ

XNAV FundX Aggressive ETF 7.46 % 0.00 %

-1.05 (-1.53%)

N/A
GTAA 0.00 % 1.25 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.77% 100% F 82% B
Dividend Return 1.09% 60% D- 20% F
Total Return 21.86% 100% F 80% B-
Trailing 12 Months  
Capital Gain 24.33% 100% F 61% D-
Dividend Return 3.01% 70% C- 40% F
Total Return 27.33% 100% F 60% D-
Trailing 5 Years  
Capital Gain 116.00% 100% F 87% B+
Dividend Return 19.56% 70% C- 66% D+
Total Return 135.56% 100% F 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 20.65% N/A N/A 83% B
Dividend Return 23.81% N/A N/A 83% B
Total Return 3.16% N/A N/A 62% D
Risk Return Profile  
Volatility (Standard Deviation) 16.67% N/A N/A 60% D-
Risk Adjusted Return 142.81% N/A N/A 100% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike